Ahmed A .M. Elnour

Dr. Ahmed A .M. Elnour

Chemical and Process Engineering Technology, Universiti Malaysia Pahang, Kuantan, Pahang, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Heliyon
Verified
Journal Article
Open access
AAAbdullah Aldhaher
Abdullah Aldhaher
FSFahimeh Shahabipour
Fahimeh Shahabipour
ASAbdullah Shaito
Abdullah Shaito
Saphwan Al-AssafSaphwan Al-Assaf
Saphwan Al-Assaf
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour
AEAbdelgadir A. Elfadil
Abdelgadir A. Elfadil
Repairing significant bone defects remains a critical challenge, raising the clinical demand to design novel bone biomaterials that incorporate osteogenic and angiogenic properties to support the regeneration of vascularized bone. Bioactive glass scaffolds can stimulate angiogenesis and osteogenesis. In addition, natural or synthetic polymers exhibit structural similarity with extracellular matrix (ECM) components and have superior biocompatibility and biodegradability. Thus, there is a need to prepare composite scaffolds of hydrogels for vascularized bone, which incorporate to improve the mechanical properties and bioactivity of natural polymers. In addition, those composites' 3-dimensional (3D) form offer regenerative benefits such as direct doping of the scaffold with ions. This review presents a comprehensive discussion of composite scaffolds incorporated with BaG, focusing on their effects on osteo-inductivity and angiogenic properties. Moreover, the adaptation of the ion-doped hydrogel composite scaffold into a 3D scaffold for the generation of vascularized bone tissue is exposed. Finally, we highlight the challenges and future of manufacturing such biomaterials.

1 January 2018 in ScienceAsia
Verified
Journal Article
Closed access
MMMohamed Elwathig Saeed Mirghani
Mohamed Elwathig Saeed Mirghani
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour
NKN.A. Kabbashi
N.A. Kabbashi
ZAZ. Alam
Z. Alam
KMKhalid Hamid Musa
Khalid Hamid Musa
AAAmina Abdullah
Amina Abdullah

11 September 2024 in Heliyon
Verified
Journal Article
Open access
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour
ABDURAHMAN NOURABDURAHMAN NOUR
ABDURAHMAN NOUR
Saussurea costus (S. costus) is a critically endangered medicinal plant that has been extensively studied for its chemical composition, significance, and therapeutic potential as traditional phytomedicine. This comprehensive review aims to provide a thorough understanding of S. costus, including its biological activities, chemical makeup, and potential therapeutic uses in biotechnology. This study investigated the pharmacological properties of S. costus, including its antimicrobial, antioxidant, and antifungal properties, and its usefulness in treating conditions such as thyroid disorders and liver injury. This study also aimed to assess and improve the techniques used to extract bioactive compounds and to develop effective methods for harvesting these compounds from medicinal plants. This review analyzed the available literature on the phytochemical makeup and bioactivity of S. costus extract using techniques such as molecular docking against SARS-CoV-2 protease, green extraction methods, and phytochemical analysis. This review revealed that S. costus possesses various pharmacological properties, including antimicrobial, antiviral, anti-inflammatory, and anticancer activities. It is effective in combating fungal infections, reducing inflammation, treating cancer, and inhibiting viral replication, and has the potential to control Candida species. Moreover, S. costus has been explored for its capacity to synthesize nanoparticles with antimicrobial properties and for its potential in treating thyroid disorders and liver injury. Despite promising results, additional research is necessary to fully comprehend the benefits of S. costus and validate its effectiveness in clinical settings. Future research should focus on standardized methodologies and rigorous clinical trials to confirm the safety and effectiveness of S. costus in various medical fields as well as further investigate its biotechnological and pharmaceutical applications.

19 December 2023 in Industrial Crops and Products
Verified
Journal Article
Closed access
ANAbdurahman H. Nour
Abdurahman H. Nour
RMRayan H. Modather
Rayan H. Modather
RYRosli M. Yunus
Rosli M. Yunus
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour
NINurul Ain Ismail
Nurul Ain Ismail

1 April 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Djabir DaddiouaissaDjabir Daddiouaissa
Djabir Daddiouaissa
AAAzura Amid
Azura Amid
MSMuhamad Shirwan Abdullah Sani
Muhamad Shirwan Abdullah Sani
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour

12 April 2024 in Journal of Agriculture and Food Research
Verified
Journal Article
Open access
KMKhalid Hamid Musa
Khalid Hamid Musa
Ahmed A .M. ElnourAhmed A .M. Elnour
Ahmed A .M. Elnour